ArticleFrontiers in immunology2023

Immune-related adverse events correlate with the efficacy of PD-1 inhibitors combination therapy in advanced cholangiocarcinoma patients: A retrospective cohort study.

Yanfang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.